Representatives from 18 partner organizations have shared the progress of the project and decided on new actions for the future.
EMA approval of lecanemab after a first negative opinion in July of this year
The BBRC coordinates the neuroimaging work, including the collection, analysis and control of magnetic resonance images.
Salvadó holds a PhD in Biomedicine from the University of Barcelona and has a solid background in the field of neuroimaging.
The event programme included six scientific posters on the centre's research.
The work, led by the BBRC and published in Alzheimer’s & Dementia, has been pivotal in securing the European Medicines Agency's approval of the Centiloid metric as a valid biomarker for Alzheimer’s disease.
It is crucial to continue research to develop new treatments that are safer and accessible to everyone.
The study, led by Dr. Laura García González, postdoctoral researcher in the Genomics Research Group of the Barcelonaßeta Brain Research Center, analyzes the biological and genetic mechanisms of Alzheimer's disease.